Belite Bio Inc Adr (BLTE)

Mar 12, 2026

Mizuho reiterates Belite Bio stock rating on NDA timeline update By Investing.com - Investing.com Nigeria

Mar 12, 2026

Mar 12, 2026

Belite Bio, Inc. Sponsored ADR (NASDAQ:BLTE) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Mar 12, 2026

Mar 11, 2026

H.C. Wainwright raises Belite Bio stock price target on NDA timeline - Investing.com Nigeria

Mar 11, 2026

Mar 10, 2026

Belite Bio Eyes 2027 Launch After Pivotal Win - TipRanks

Mar 10, 2026

Mar 10, 2026

Belite Bio Details Phase 3 DRAGON Win as Tinlarebant Cuts Stargardt Lesion Growth 36% at Conference - MarketBeat

Mar 10, 2026

Mar 09, 2026

Belite Bio (BLTE) to Release Earnings on Monday - MarketBeat

Mar 09, 2026

Mar 07, 2026

What is HC Wainwright’s Forecast for Belite Bio Q1 Earnings? - Defense World

Mar 07, 2026

Mar 06, 2026

(BLTE) Movement as an Input in Quant Signal Sets - Stock Traders Daily

Mar 06, 2026

Mar 06, 2026

Q1 Earnings Forecast for Belite Bio Issued By HC Wainwright - MarketBeat

Mar 06, 2026

Mar 04, 2026

Mizuho reiterates Belite Bio stock rating on NDA timeline update - Investing.com

Mar 04, 2026

Mar 04, 2026

Belite Bio Q4 Earnings Call Highlights - Defense World

Mar 04, 2026

Mar 04, 2026

Belite Bio (NASDAQ:BLTE) Given New $266.00 Price Target at Cantor Fitzgerald - Defense World

Mar 04, 2026

Mar 03, 2026

Belite Bio (NASDAQ:BLTE) Price Target Raised to $200.00 at HC Wainwright - MarketBeat

Mar 03, 2026

Mar 03, 2026

Belite Bio (BLTE) Q4 2025 Earnings Call Transcript - The Globe and Mail

Mar 03, 2026

Mar 03, 2026

Belite Bio (NASDAQ:BLTE) Price Target Raised to $201.00 - MarketBeat

Mar 03, 2026

Mar 03, 2026

Belite Bio stock price target raised to $217 by Benchmark on trial data - Investing.com

Mar 03, 2026

Mar 03, 2026

Belite Bio (NASDAQ:BLTE) Price Target Raised to $266.00 at Cantor Fitzgerald - MarketBeat

Mar 03, 2026

Mar 03, 2026

Cantor Fitzgerald raises Belite Bio stock price target on pricing outlook - Investing.com

Mar 03, 2026

Mar 02, 2026

Earnings call transcript: Belite Bio beats Q4 2025 EPS expectations, stock dips slightly - Investing.com

Mar 02, 2026

Mar 02, 2026

Belite Bio (NASDAQ:BLTE) Shares Down 8.6%What's Next? - MarketBeat

Mar 02, 2026

Mar 02, 2026

Belite Bio to Participate in the Leerink Global Healthcare Conference - The Manila Times

Mar 02, 2026

Mar 02, 2026

Belite Bio Posts 2025 Results as Tinlarebant Nears NDA Filing After Phase 3 Win - TipRanks

Mar 02, 2026

Mar 02, 2026

Belite Bio Reports Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update - The Manila Times

Mar 02, 2026

Feb 27, 2026

Stargardt Disease Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | Ocugen, Kubota Vision Inc, Nanoscope Therapeutics, RBP4 Pty Ltd, Stargazer Pharma, Belite Bio, Alkeus Pharma - Barchart.com

Feb 27, 2026

Feb 23, 2026

Liquidity Mapping Around (BLTE) Price Events - Stock Traders Daily

Feb 23, 2026

Feb 23, 2026

Belite Bio to Host Webcast on March 2, 2026, to Discuss Preliminary, Unaudited Fourth Quarter ... - Caledonian Record

Feb 23, 2026

Feb 22, 2026

China Universal Asset Management Co. Ltd. Acquires New Position in Belite Bio, Inc. Sponsored ADR $BLTE - Defense World

Feb 22, 2026

Feb 20, 2026

Belite Bio (NASDAQ:BLTE) Shares Gap UpStill a Buy? - MarketBeat

Feb 20, 2026

Feb 17, 2026

Belite Bio, Inc (BLTE) Stock Report: Analyst Ratings Signal Strong Buy with 9.62% Potential Upside - DirectorsTalk Interviews

Feb 17, 2026

Feb 17, 2026

Darwin Global discloses 8.1% Belite Bio (BLTE) holding in 13G/A - Stock Titan

Feb 17, 2026

Feb 16, 2026

Belite Bio, Inc. Sponsored ADR (NASDAQ:BLTE) Sees Large Growth in Short Interest - Defense World

Feb 16, 2026

Feb 15, 2026

Belite Bio, Inc. Sponsored ADR (NASDAQ:BLTE) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat

Feb 15, 2026

Feb 14, 2026

Belite Bio, Inc. Sponsored ADR (NASDAQ:BLTE) Short Interest Up 49.4% in January - MarketBeat

Feb 14, 2026

Feb 12, 2026

Why (BLTE) Price Action Is Critical for Tactical Trading - Stock Traders Daily

Feb 12, 2026

Feb 10, 2026

Belite Bio, Inc (BLTE) Stock Analysis: Biotechnology Innovator With 4.98% Potential Upside - DirectorsTalk Interviews

Feb 10, 2026

Feb 09, 2026

Belite Bio (NASDAQ:BLTE) Shares Down 5.2%Here's Why - MarketBeat

Feb 09, 2026

Feb 09, 2026

Belite Bio (BLTE) Valuation Check After Completing Enrollment In Pivotal DRAGON II Trial - Sahm

Feb 09, 2026

Feb 03, 2026

Belite Bio stock hits all-time high at 177.28 USD By Investing.com - Investing.com Nigeria

Feb 03, 2026

Feb 03, 2026

Belite Bio stock hits all-time high at 177.28 USD - Investing.com

Feb 03, 2026

Feb 03, 2026

Belite Bio (NASDAQ:BLTE) Reaches New 12-Month HighHere's What Happened - MarketBeat

Feb 03, 2026

Feb 01, 2026

Belite Bio (BLTE) Valuation Check As Phase 3 DRAGON Tinlarebant Data Presentations Approach - Sahm

Feb 01, 2026

Feb 01, 2026

Understanding Momentum Shifts in (BLTE) - Stock Traders Daily

Feb 01, 2026

Jan 29, 2026

Belite Bio Announces Participation at the 41st Asia-Pacific Academy of Ophthalmology Congress (APAO) - markets.businessinsider.com

Jan 29, 2026

Jan 28, 2026

H.C. Wainwright reiterates Buy rating on Belite Bio stock with $185 target By Investing.com - Investing.com South Africa

Jan 28, 2026

Jan 28, 2026

H.C. Wainwright reiterates Buy rating on Belite Bio stock with $185 target - Investing.com Nigeria

Jan 28, 2026

Jan 28, 2026

Belite Bio's (BLTE) Buy Rating Reiterated at HC Wainwright - MarketBeat

Jan 28, 2026